Russian SARS2 Vaccine safe, 92% effective for even 60s plus



“The efficacy looks good, including in the over 60s,” said Danny Altmann, a professor of immunology at Imperial College London. “It’s good to have another addition to the global arsenal.”

2,144 Volunteers over 60 in the Sputnik V trial proved the vaccine to be 91.8% effective. There were no serious side-effects reported that could be associated with the vaccine a detailed peer-reviewed report in The Lancet said.

The Sputnik V vaccine can be stored in refrigerators and thus easily distributed and it will require two distinctly different doses, twenty-one days apart.


by Melissa Hemingway


 

Safe and effective Russian Vaccine added to teh stable of good vaccines

“What then of the Sputnik V COVID-19 vaccine data published in the Lancet? The earlier phase 1/2 data published in September, 2020, showed promising safety results and gave an indication that the immune response was at a level consistent with protection.
Recipients generated robust antibody responses to the spike protein, which included neutralizing antibodies, the proportion of the total immunoglobulin that inhibits the virus binding to its receptor. They also showed evidence of T-cell responses, consistent with an immune response that should not quickly wane.” Reports the highly respected global medical journal, The Lancet. Photo Credit: Melissa Hemingway. 

“The Sputnik V vaccine uses a heterologous recombinant adenovirus approach using adenovirus 26 (Ad26) and adenovirus 5 (Ad5) as vectors for the expression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. The use of two varying serotypes, which are given 21 days apart, is intended to overcome any pre-existing adenovirus immunity in the population,” notes the Lancet.

Read detailed medical evaluation of the Phase III trials from “Sputnik V COVID-19 vaccine candidate appears safe and effective.”

Russian citizens have already been offered the vaccine since the start of the year.  Frontline workers in Russia were given the vaccine last year.

Current Global COVID-19 Statistics (June 29, 2022)

254 Locales report 550,329,302 COVID-19 cases of which there are 16,429,329 active cases, therefore 527,526,412 recoveries and 6,373,561 fatalities.

GMT 2022-06-29 05:46

Data reported should be in accordance with the applied case definitions and testing strategies in each locale as their governments report daily or from time to time. All data researched and published by The RINJ Foundation and partners in CSPaC.

©The RINJ Foundation 2020-2022-06-29T05:46:25Z #Singapore-SK-HUK-77
RINJ is with Civil Society Solidarity Partners against COVID-19.

SARS2 Update 2022-06-29 05:46 GMT

  • Global Population: 7,903,501,966
  • 254 Regions reported 550,329,302 cases
  • 16,429,329 cases active
  • 6,373,561 people reported killed by COVID-19
  • 1.16% is current Case Fatality Rate (CFR)
  • 527,526,412 survived COVID-19
Beta Technology Global Estimates
  • 38.51% of all humans (3,043,321,040) have been infected
  • 0.63% Global estimated inferred average Infection Fatality Rate (IFR)
    (influenza is .1% or 6 per 100k (2019))
  • 19,113,990 Total deaths (CSPaC.net estimated actual) including errors, unexpected deaths with pneumonia indications with no history, and unreported likely-cause excess deaths such as people who never went to a hospital but had COVID-19 indications but never tested.

See The Lancet estimate of excess mortality from COVID-19 (Download PDF) in 191 countries/territories and 252 subnational units of select countries, from 1 January 2 0 2 0, to 31 December 2 0 2 1.

USA (88,626,717)
  • 145.42% of the USA may have been infected including reported + estimated unreported mild and estimated asymptomatic (483,949,290.02) persons, some of whom may not have been ill in their first course of the disease, but could have spread the disease.
  • 1.18% is USA current Case Fatality Rate (CFR) &
  • 0.27% is estimated inferred average Infection Fatality Rate (IFR)
  • 1,306,663 estimated total COVID-19 deaths including unreported likely-cause excess deaths. According to projections of IHME, IHME calculation of excess deaths is slightly higher than what CSPaC is showing.
  • See The Lancet estimate of excess mortality from COVID-19 (Download PDF) in 191 countries/territories and 252 subnational units of select countries, from 1 January 2 0 2 0, to 31 December 2 0 2 1.

    The American Epicenter has 17.51 % of global 'active' cases (2,876,764 USA / 16,429,329 Global), people infected with COVID-19 now.

Below: CSPAC estimated 2022-06-29 03:58 GMT COVID-19 data for India.

EPICENTER-2: India (43,436,433)

Reported*Cases*Deaths*CFR*Recovered
India43,436,433525,0471.2%42,797,092
*Reported by India but understated.

Note: India's reported death sum and cured data are widely seen among epidemiologists and biostatisticians as unreliable. For example, 3,045,220 is CSPAC estimated sum of deaths while India reports 525,047, creating the largest discepency in the world. India might only report hospital tested cases. Sources among hundreds of nurses and other medical practitioners provide a picture that in summary concludes most cases never present in a hospital especially in northern provinces where health care is less available and utilization is low anyway because of poverty, hence most people die at home in India. This theory could explain discrepancies between reported data and algorithmic estimates.

LocaleCasesDeathsActive
India reported:43,436,433525,047114,294
India estimates:240,203,4743,045,220490,335

Data collected and reported by: Civil Society Solidarity Partners against COVID-19